Exelixis Stock Performance
EXEL Stock | USD 23.86 0.25 1.06% |
The firm shows a Beta (market volatility) of 0.32, which means possible diversification benefits within a given portfolio. As returns on the market increase, Exelixis' returns are expected to increase less than the market. However, during the bear market, the loss of holding Exelixis is expected to be smaller as well. Exelixis right now shows a risk of 1.61%. Please confirm Exelixis downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Exelixis will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Low | High |
Very Weak
Over the last 90 days Exelixis has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent technical and fundamental indicators, Exelixis is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
Actual Historical Performance (%)
One Day Return 1.06 | Five Day Return (0.67) | Year To Date Return (0.29) | Ten Year Return 605.92 | All Time Return 61.76 |
1 | Exelixis earnings beat by 0.10, revenue fell short of estimates | 02/06/2024 |
2 | Investors one-year returns in Exelixis have not grown faster than the companys underlying earnings growth | 02/08/2024 |
3 | Disposition of 10630 shares by Dana Aftab of Exelixis at 20. subject to Rule 16b-3 | 02/15/2024 |
4 | Algert Global LLC Purchases 33,510 Shares of Exelixis, Inc. | 02/23/2024 |
5 | Exelixis Inc at Oppenheimer Healthcare Life Sciences Conference Transcript | 03/04/2024 |
6 | Sectoral Asset Management Inc. Makes New Investment in Exelixis, Inc. | 03/06/2024 |
7 | EXEL Industries Number of shares and voting rights as of 02.29.2024 | 03/07/2024 |
8 | Exelixis, Inc. Receives Average Recommendation of Moderate Buy from Analysts - Defense World | 03/11/2024 |
9 | Ryvu Therapeutics Summarizes 2023 Fiscal Year and Provides Corporate Update | 03/13/2024 |
10 | Insider Trading | 03/15/2024 |
11 | Disposition of 23304 shares by Michael Morrissey of Exelixis at 21.51 subject to Rule 16b-3 | 03/20/2024 |
12 | Disposition of 23491 shares by Alan Garber of Exelixis at 19.57 subject to Rule 16b-3 | 03/21/2024 |
13 | Exelixis director Garber Alan M sells shares worth over 460k | 03/25/2024 |
Begin Period Cash Flow | 502.7 M |
Exelixis |
Exelixis Relative Risk vs. Return Landscape
If you would invest 2,399 in Exelixis on December 29, 2023 and sell it today you would lose (13.00) from holding Exelixis or give up 0.54% of portfolio value over 90 days. Exelixis is currently generating 0.0041% in daily expected returns and assumes 1.6119% risk (volatility on return distribution) over the 90 days horizon. In different words, 14% of stocks are less volatile than Exelixis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Exelixis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Exelixis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Exelixis, and traders can use it to determine the average amount a Exelixis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0025
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | EXEL |
Estimated Market Risk
1.61 actual daily | 14 86% of assets are more volatile |
Expected Return
0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Exelixis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Exelixis by adding Exelixis to a well-diversified portfolio.
Exelixis Fundamentals Growth
Exelixis Stock prices reflect investors' perceptions of the future prospects and financial health of Exelixis, and Exelixis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Exelixis Stock performance.
Return On Equity | 0.0874 | ||||
Return On Asset | 0.0355 | ||||
Current Valuation | 6.35 B | ||||
Shares Outstanding | 303.19 M | ||||
Price To Earning | 48.17 X | ||||
Price To Book | 3.16 X | ||||
Price To Sales | 3.95 X | ||||
Revenue | 1.83 B | ||||
Gross Profit | 1.55 B | ||||
EBITDA | 196.6 M | ||||
Net Income | 207.76 M | ||||
Cash Per Share | 4.77 X | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 6.08 X | ||||
Cash Flow From Operations | 333.32 M | ||||
Earnings Per Share | 0.65 X | ||||
Total Asset | 2.94 B | ||||
Retained Earnings | (173.35 M) | ||||
Current Asset | 178.66 M | ||||
About Exelixis Performance
To evaluate Exelixis Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Exelixis generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Exelixis Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Exelixis market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Exelixis's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for 2024 | ||
Return On Capital Employed | 0.13 | 0.13 | |
Return On Assets | 0.09 | 0.09 | |
Return On Equity | 0.10 | 0.10 |
Things to note about Exelixis performance evaluation
Checking the ongoing alerts about Exelixis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Exelixis help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Exelixis has a strong financial position based on the latest SEC filings | |
Over 87.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from investing.com: Exelixis director Garber Alan M sells shares worth over 460k |
- Analyzing Exelixis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Exelixis' stock is overvalued or undervalued compared to its peers.
- Examining Exelixis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Exelixis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Exelixis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Exelixis' stock. These opinions can provide insight into Exelixis' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.Note that the Exelixis information on this page should be used as a complementary analysis to other Exelixis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Exelixis Stock analysis
When running Exelixis' price analysis, check to measure Exelixis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelixis is operating at the current time. Most of Exelixis' value examination focuses on studying past and present price action to predict the probability of Exelixis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelixis' price. Additionally, you may evaluate how the addition of Exelixis to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Exelixis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share 0.65 | Revenue Per Share 5.753 | Quarterly Revenue Growth 0.131 | Return On Assets 0.0355 |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.